Biontech founder Uğur Şahin told the audience something about the upcoming vaccine for the Omicron variant.
Biontech Gründer Uğur Şahin lässt wieder einen vom Stapel.
In 2020, BioNTech, partnering with Pfizer for testing and logistics, developed the RNA vaccine BNT162b2 for preventing COVID-19 infections, which offers a 91% efficacy[4] in preventing confirmed COVID-19 occurring at least 7 days after the second dose of vaccine. (wikipedia)
▶️ 3Speak
